REVANCE THERAPEUTICS INC stock forecast: up to 15.82 USD RVNC stock price prognosis


Forecast for Fri 17 Dec 2021 price 18.87

REVANCE THERAPEUTICS INC stock price forecast for further price development up to 2.46% (time horizon: 1 day) and price target of 15.82 USD. Negative news sentiment. Short-term (time horizon: 2 weeks) REVANCE THERAPEUTICS INC share price prediction for 2021-12-17 with daily closed price projections

Key Facts

Symbol RVNC 

ISIN US7613301099 

CUSIP 761330109

Currency USD

Category Pharmaceutical Preparations

Forecast price change %

News sentiment (-0.62)

Finance numbers

Revenue 28,566,000.0

Earnings per share -4.79

On our site we made daily predictions for finance products based on statistical analysis. You can export / download forecasted data as CSV file, no login required. The information can be used for day trading.

The forecast (dashed curve) of the share price performance is based on historical data. Our forecast model is based on mathematical, statistical methods. The website offers price forecasts and analysis tools for equities and other securities, which are exclusively based on the prices of these securities in the past. Information about these prices is provided to us by third parties. Although we believe, If we believe that our sources are reliable, we cannot guarantee the accuracy, completeness, timeliness and correct sequencing of this information. We do not investigate the issuers of the securities to which our forecasts relate, nor do we consider any financial data or other data of such issuers with the exception of the past prices of the securities. Therefore, our forecasts do not constitute an analysis of other commercial or financial factors or circumstances, that may be relevant for future security price flows. Investments require additional considerations. Our forecasts cannot reflect the specific situation. Experience and risk profile of an individual investor or the tax implications an investment may have for the investor. Although we believe that our mathematical models are a tool to try to explore the possibility for future price development with the help of past performance, such developments are subject to a multitude of different influences. and therefore not really predictable. We cannot guarantee the success of any investment you make based on the information published here. This website is for information purposes only. All information and data on this website cannot be guaranteed to be accurate, accuracy, completeness and appropriateness - neither explicit nor implicit.

Summerized Form 10-K with GPT-2

We are dedicated to making a difference by transforming patient experiences. Our clinical trials have been and may continue to be affected by the COVID-19 pandemic. The trial was originally designed to include 128 subjects. We released topline results from the UFL Trial in December of 2020. DaxibotulinumtoxinA for Injection was well-tolerated at all dose levels. In February 2021, we announced topline data from the JUNIPER Phase 2 trial. On May 2, 2019 our European Patent No. We are vigorously defending this patent in the European Patent Office. Once the submission is accepted for filing, the FDA begins an in-depth review of the BLA. Other states in the United States are also beginning to propose laws similar to the CCPA. In many jurisdictions, enforcement actions and consequences for noncompliance are rising. Cyberattacks and other malicious internet-based activity continue to increase. In addition, we have had to put in place a work from home policy for all employees. Teoxane must do the same with its PMAs to the FDA for the RHA® Pipeline Products. We do not have control over Teoxane's compliance with these regulations and standards. The amount and timing of these possible charges are not yet known. Leadership transitions can be inherently difficult to manage. A breach of confidentiality could significantly affect our competitive position. This can be expensive, particularly for a company of our size, and time-consuming. We may fail to report adverse events we become aware of within the prescribed timeframe.

Summerized Form 10-K with GPT-2
Candlestick patterns

Candlestick patterns can be used as additional information for price prediction. Following list show which pattern applies on latest price information.

Institutional ownership list is based on filling form information

Holding name Date Amount
Point72 Hong Kong Ltd 2021-03-31 587
Squarepoint Ops LLC 2021-03-31 10067

Fund ownership list is based on filling form information

Fund name Date Amount Profile
Fidelity Commonwealth Trust 2021-05-31 27260 Long
Fidelity Select Portfolios 2021-05-31 700000 Long
Fidelity Concord Street Trust 2021-05-31 105704 Long
SPARROW FUNDS 2021-05-31 9040 Long
Fidelity Salem Street Trust 2021-04-30 462176 Long


CIK Name Date Action T-Test 1day T-Test 7day T-Test 14day T-Test 30day
1818576 Rankin Aubrey 2021-08-16 SALE Accept Accept Accept Accept

REVANCE THERAPEUTICS INC Short Volume Ratio is shown in the diagram. Short volume sales can be seen as an investor sentiment.

On-Balance Volume information for REVANCE THERAPEUTICS INC. On-Balance Volume information can be an indicator for bullish or bearish outcome.

Accumulation / Distribution (A/D) indicator information for REVANCE THERAPEUTICS INC. The indicator identify divergences between price and volume flow.

Aroon Oscillator information for REVANCE THERAPEUTICS INC. The trend-following indicator can show the strengh of a current trend and likelihood that trend can continue.

Average Directional Index (ADX) information for REVANCE THERAPEUTICS INC. The index can be used to identify the strengh of a trend.

Moving Average Convergence Divergence (MACD) for REVANCE THERAPEUTICS INC. The indicator helps to predict trend direction and the momentum of the trend.

Stochastic Oscillator as momentum indicator for REVANCE THERAPEUTICS INC. The indicator is useful for identifying overbought and oversold levels.

Relative Strength Index (RSI) for REVANCE THERAPEUTICS INC. RSI is a momentum oscillator that measures the speed and change of price development. The momentum indicator was created by analyst Welles Wilder. The result compares recent gains and losses over restricted time period. Primary usage of the indicator is to identify overbought or oversold signals. When RSI indicator reaches a value of 70 it could mean that speculators should consider selling, suggests Wilder and Chong. Or vice versa when selling excess at which the RSI Indicators show a value of 30 [ Relative Strength Index for Developing Effective Trading Strategies in Constructing Optimal Portfolio ].

52W High 52W Low Market Cap

Similar shares



Figure below show the stock predictions.
Date Closing price Prediction was updated
2021-11-04 15.82 2021-10-23 09:31
2021-11-01 15.19 2021-10-23 09:31
2021-11-02 15.88 2021-10-23 09:31
2021-11-03 15.67 2021-10-23 09:31
2021-11-05 15.68 2021-10-23 09:31
2021-11-08 16.43 2021-10-23 09:31
2021-11-09 15.99 2021-10-23 09:31
2021-10-25 14.72 2021-10-23 09:31
2021-10-26 16.17 2021-10-23 09:31
2021-10-27 16.54 2021-10-23 09:31
2021-10-28 16.40 2021-10-23 09:31
2021-10-29 15.29 2021-10-23 09:31
2021-11-10 16.42 2021-10-23 09:31
2021-11-11 16.83 2021-10-23 09:31
2021-11-12 17.00 2021-10-23 09:31
2021-11-25 17.80 2021-10-23 09:31
2021-11-26 17.85 2021-10-23 09:31
2021-11-29 17.87 2021-10-23 09:31
2021-11-30 18.09 2021-10-23 09:31
2021-12-01 18.09 2021-10-23 09:31
2021-12-02 18.15 2021-10-23 09:31
2021-12-03 18.20 2021-10-23 09:31
2021-12-06 18.28 2021-10-23 09:31
2021-12-07 18.36 2021-10-23 09:31
2021-11-15 17.09 2021-10-23 09:31
2021-11-16 17.06 2021-10-23 09:31
2021-11-17 17.33 2021-10-23 09:31
2021-11-18 17.35 2021-10-23 09:31
2021-11-19 17.38 2021-10-23 09:31
2021-11-22 17.31 2021-10-23 09:31
2021-11-23 17.48 2021-10-23 09:31
2021-11-24 17.71 2021-10-23 09:31
2021-12-08 18.40 2021-10-23 09:31
2021-12-09 18.47 2021-10-23 09:31
2021-12-10 18.53 2021-10-23 09:31
2021-12-13 18.61 2021-10-23 09:31
2021-12-14 18.66 2021-10-23 09:31
2021-12-15 18.74 2021-10-23 09:31
2021-12-16 18.81 2021-10-23 09:31
2021-12-17 18.87 2021-10-23 09:31